8
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Hyperthermia, chemotherapeutic agents and oncogenic transformation

, , &
Pages 311-320 | Received 15 Oct 1985, Published online: 09 Jul 2009

References

  • Barlogie B., Corry P. N., Drewinko B. In vitro thermoehcmotherapy of human colon cancer cells with a's-dichlorodiammine platinum (II) and mitomycin C. Cancer Research 1980; 40: 1165–1168
  • Dahl O., Mella O. Effect of timing and sequence of hyperthermia and cyclophosphamide on a neutrogenic rat tumor in vivo. Cancer 1983; 52: 983–987
  • Dewey W C. Interaction of heat with radiation and chemotherapy. Cancer Research 1984; 44: 4714–4720, Suppl.
  • Fairman H D. The treatment of head and neck carcinoma with adriamycin and bleomycin using adjuvant hyperthermia. Journal of Laryngology and Otolaryngology 1982; 96: 251–263
  • Hahn G M, Braun J., Har-Kedar I. Thermochemotherapy: Synergism between hyperthermia 42–43°C and adriamycin (or bleomycin) in mammalian cell inactivation. Proceedings of the National Academy of Sciences, U.SA 1975; 72: 937–940
  • Hall E J, Miller R. C., Osmak R., Zimmerman M. A comparison of the incidence of oncogenic transformation produced by X-rays, misodnidazole and chemo-therapeutic agents. Radiology 1982; 145: 521–526
  • Hall E J. Oncogenic transformation studies with hyperthermia and X-rays. Hyperthermic Oncology 1984, Vol. 1, Summary Papers, J. Overgaard. Taylor & Francis, London, Philadelphia 1985; 479–483
  • Hall E J, Roizin-Towle L. Biological effects of heat. Cancer Research 1984; 44: 4708–4713, Suppl
  • Hall E J, Hei T. K. Oncogenic transformation with radiation and chemicals: a review. InternationalJournal of Radiation Biology 1985; 48: 1–18
  • Han A., Elkind M. Transformation of mouse C3H 10T1/2 cells by simple and fractionated doses of X-rays and fission spectrum neutrons. Cancer Research 1979; 39: 123–130
  • Hei T K, Hall E. J., Osmak R. S. Asbestos, radiation and oncogenic trans formation. British Journal of Cancer 1984; 50: 717–720
  • Hei T K, Geard D. R., Osmak R. S., Hall E. J. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers. International Journal of Radiation, Oncology, Biology, Physics 1985; 11: 1653–1658
  • Huband J., Albernethy D. J., Benekio C. J. Potential role of treatment artifact in the effect of ceil density upon frequencies of C3H 10T1/2 cells transformation. Cancer Research 1985; 45: 6314–6321
  • Juarez-Salinas H., Duran-Torres G., Jacobson M. Alternation of poly (ADP-ribose) metabolism by hyperthermia. Biochemical and Biophysical Research Communications 1984; 122: 1381–1388
  • Kennedy A R, Little J. B. Investigation of the mechanism for enchancement of radiation transformation in vitro by 12–0-tetradecanoyl-phenbol-13-acetate. Carcinogenesis 1980; 1: 1039–1047
  • Meyn R E, Corry P. N., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cw-diamine dichloroplatinum (II). Cancer Research 1980; 40: 1136–1139
  • Rege V B, Leone L. A., Soderberg C. H., Jr., Coleman G. V., Robidoux H. J., Fijman R., Brown J. Hyperthermic adjuvant perfusion chemotherapy for stage 1 malignant melanoma of the extremity with literature review. Cancer 1983; 52: 2033–2039
  • Reznikoff C A, Brankow D. W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse cells sensitive to post confluence inhibition of division. Cancer Research 1973a; 33: 3231–3237
  • Reznikoff C A, Bertram J. S., Brankow D. W., Heidelberger C. Quantitative and qualitative studies on chemical transformation of cloned C3 H mouse embryo cells sensitive to post confluence inhibition of cell division. Cancer Research 1973b; 33: 3239–3249
  • Stehlin J S. Hyperthermic perfusion for melanoma of the extremities: Experience with 165 patients, 1967 to 1969. Annals of the New York Academy of Sciences 1980; 335: 352–355
  • Watanabe M., Nkaido O., Sugahara T. Simultaneous hyperthermia at 43°C reduces radiation induced malignant transformation frequencies in Golden Hamster embryo cells. International Journal of Cancer 1984; 33: 483–489

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.